Praxis Precision Medicines PRAX
$300.43 −$10.47 (-3.37%)
Market closed · Nov 22, 5:10 am ET · Last extended-hours $300.43 0.00%
Open$310.07
Prev close$310.90
Day range$298.54 – $314.15
Volume806.2K
Market cap$8.40B
P/E (TTM)–
Dividend yield–
PRAX Stock News
Headlines matching Praxis Precision Medicines or the PRAX ticker, most recent first.
- Needham Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $582
- A Quick Look at Today's Ratings for Praxis Precision Medicines(PRAX.US), With a Forecast Between $441 to $1,201
- LifeSci Capital Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $754
- A Quick Look at Today's Ratings for Praxis Precision Medicines(PRAX.US), With a Forecast Between $462 to $800
- H.C. Wainwright Sticks to Its Buy Rating for Praxis Precision Medicines (PRAX)
- Goldman Sachs Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $575
- Goldman Sachs Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Raises Target Price to $575 Positive
- Oppenheimer Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $650
- Raymond James Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Announces Target Price $945
- LifeSci Capital Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $719
- Jefferies Initiates Praxis Precision Medicines(PRAX.US) With Buy Rating, Announces Target Price $447
- Piper Sandler Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $1,200
- RBC Capital Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $449
- Guggenheim Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $800
- Jefferies Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $550
No comments yet — be the first to weigh in on PRAX.
Sign in to join the discussion.